
...
By Aaliyan Mohammed
Contributing Sports Writer
0
Share
Newsweek is a Trust Project member
See more of our trusted coverage when you search.Prefer Newsweek on Googleto see more of our trusted coverage when you search.
The Philadelphia Phillies will have to compete with other teams on the open market if they wish to bring Kyle Schwarber back to the team.
Schwarber will turn 33 soon, and his age will be a key factor to teams looking to sign him. He has not shown any signs of decline, but may be reaching a point where he cannot be the focal point of a team's offense. In Philadelphia, he is surrounded by stars like Trea Turner and Bryce Harper. However, Phillies president Dave Dombrowski recently questioned whether Harper could return to being an elite-level player.
If Schwarber also feels like Harper is not going to be able to help get him to another World Series, he could be in search of a new running mate. There are plenty of young stars around the league that Schwarber could join forces with, but FanSided's Chris Landers suggested he swap out Harper for young Boston Red Sox phenom Roman Anthony.
Read More on MLB

...
"It's not long before we're talking about him as one of the best players in the sport, period, and he's still just 21; were it not for the guy one spot ahead of him on this list, you really couldn't do much better if you were an aging star looking for someone to hitch your wagon to for the rest of your prime," Landers wrote Saturday. "Plus, we know the Boston Red Sox are interested in Schwarber's services, and why wouldn't they be? This offense was missing his kind of pop last season, and while Masataka Yoshida is around as a DH option, is that really stopping you from acquiring someone of Schwarber's caliber?"
The Phillies may have their own reservations about paying Schwarber at this age. However, on a young team like the Red Sox, Schwarber would need to be a complementary piece to Anthony and the other young, talented players in Boston.
More MLB: Blue Jays’ Bo Bichette Projected to Get 8-Year, $187M Deal Despite ‘Red Flag’
View 0 Comments
Submit Correction
View Editorial & AI Guidelines